November 25, 2021
Detecting the previously undetectable
Read More
Developing AI-Enabled Optical Detection Systems for Tumor Margin Assessment and Tissue Characterization
Unseen cancer revealed
The New Generation of Assessment
When it comes to cancer treatment, even the smallest amount of leftover tissue can lead to recurrence. Reveal combines an AI engine that provides real-time tissue diagnostics, sophisticated optical techniques, and an intuitive probe that can be manipulated easily during surgery. We give world-class surgeons the ability to confidently identify previously undetected cancerous tissue in vivo, giving patients a greater chance at a healthier life.
What Is Reveal?
Our Technology
Surgeons are often faced with critical decisions in real-time. With little margin for error, greater tumor cell identification and precise excision are key – remove too little tissue and risk fatal recurrences or remove too much and cause profound neurological damage. Learn more about how Reveal’s technology is tackling this problem.
The Sentry™
Our future flagship product for neurosurgery. Our intraoperative platform brings the diagnostic capability of Raman Spectroscopy and the power of AI to the hands of surgeons.
We aim to allow surgeons to make in vivo, real-time measurements of brain tissue and identify the presence of invasive cancer cells, at the sub-millimeter scale. Investigational studies have shown Raman-based classifiers can reveal invasive cancer past the boundary of MRI with high accuracy, sensitivity, and specificity. We are developing our product to harness this precision for the moments it’s needed most. Learn more on our Technology Page.
*Currently for investigational use only
Become A Research Partner
With your help, we can continue to discover new methods of tissue characterization, together changing the landscape of medicine.
Let's Talk
In The Press
November 19, 2021
Made in Quebec: Illuminating hidden brain cancer cells
Read More
November 09, 2021
ODS Medical Inc has rebranded as Reveal Surgical
Read More
September 01, 2020
ODS Medical, Inc. closes a new financing round to further support product development diversification of applications
Read More
August 01, 2019
ODS Medical Inc. announces Sentry™ System prototype for real-time Raman spectroscopy receives Health Canada testing authorization
Read More
May 27, 2019
Innovation, Science and Economic Development Canada announces $49 Million investment in DHDP
Read More
October 25, 2018
ODS Medical joins forces with two American Giants
Read More
July 01, 2018
ODS Medical is a 2018 Medtech Innovator Showcase Company
Read More
January 12, 2018
Frédéric Leblond in the running for discovery of the year
Read More
June 29, 2017
Montreal-developed probe could be breakthrough in finding cancer (Montreal CTV News)
Read More